Pages that link to "Q36318579"
Jump to navigation
Jump to search
The following pages link to 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. (Q36318579):
Displaying 50 items.
- Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA (Q21245354) (← links)
- Early alterations of brain cellular energy homeostasis in Huntington disease models (Q23912810) (← links)
- Mitochondria, calcium and cell death: a deadly triad in neurodegeneration (Q24646020) (← links)
- The biochemistry of the metabolic poison propionate 3-nitronate and its conjugate acid, 3-nitropropionate (Q26866019) (← links)
- Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease (Q27011417) (← links)
- Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model. (Q27314860) (← links)
- The Combined Structural and Kinetic Characterization of a Bacterial Nitronate Monooxygenase from Pseudomonas aeruginosa PAO1 Establishes NMO Class I and II (Q27684586) (← links)
- Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role? (Q28076243) (← links)
- Shaping the role of mitochondria in the pathogenesis of Huntington's disease (Q28384036) (← links)
- Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis (Q28386202) (← links)
- Energy failure: does it contribute to neurodegeneration? (Q28389950) (← links)
- S-glutathionylation: from molecular mechanisms to health outcomes (Q30398587) (← links)
- Mouse models of Huntington's disease and methodological considerations for therapeutic trials (Q30481208) (← links)
- Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent. (Q31130991) (← links)
- Proteasome activator enhances survival of Huntington's disease neuronal model cells (Q33275949) (← links)
- Normal aging modulates the neurotoxicity of mutant huntingtin (Q33413070) (← links)
- Stem Cells Transplantation and Huntington's Disease (Q33614689) (← links)
- Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington's Disease Induced by 3-Nitropionic Acid (Q33636220) (← links)
- HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. (Q33649916) (← links)
- Construction of a Recyclable Genetic Marker and Serial Gene Deletions in the Human Pathogenic Mucorales Mucor circinelloides (Q33877277) (← links)
- Neuronal apoptosis in the striatum of rats treated with 3-nitropropionic acid is not triggered by cell-cycle re-entry (Q33986736) (← links)
- D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease (Q34023773) (← links)
- Differential roles of Epac in regulating cell death in neuronal and myocardial cells (Q34025440) (← links)
- Altered microRNA regulation in Huntington's disease models (Q34146968) (← links)
- Targeting reactive astrogliosis by novel biotechnological strategies (Q34200928) (← links)
- Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease (Q34412171) (← links)
- Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. (Q34440282) (← links)
- Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin (Q34483577) (← links)
- Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop (Q34552736) (← links)
- Thalamic metabolism and symptom onset in preclinical Huntington's disease (Q34692568) (← links)
- Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration (Q34706597) (← links)
- DRAM1 regulates autophagy flux through lysosomes (Q34733718) (← links)
- Specific reactions of different striatal neuron types in morphology induced by quinolinic acid in rats (Q35121495) (← links)
- Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid (Q35540810) (← links)
- HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation (Q35840562) (← links)
- Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington's Disease. (Q35906784) (← links)
- pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. (Q35939218) (← links)
- Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat. (Q36019780) (← links)
- Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases (Q36082495) (← links)
- Promethazine protects against 3-nitropropionic acid-induced neurotoxicity. (Q36253348) (← links)
- Spatiotemporal expression of osteopontin in the striatum of rats subjected to the mitochondrial toxin 3-nitropropionic acid correlates with microcalcification. (Q36323553) (← links)
- Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease (Q36372732) (← links)
- 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair (Q36498096) (← links)
- c-Fos Protects Neurons Through a Noncanonical Mechanism Involving HDAC3 Interaction: Identification of a 21-Amino Acid Fragment with Neuroprotective Activity (Q36515603) (← links)
- Korean Red Ginseng Extract Attenuates 3-Nitropropionic Acid-Induced Huntington's-Like Symptoms (Q36599891) (← links)
- Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients. (Q36916483) (← links)
- Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body (Q36999830) (← links)
- Stem cell-based cell therapy for Huntington disease: a review (Q37028233) (← links)
- Melatonin ameliorates injury and specific responses of ischemic striatal neurons in rats (Q37047638) (← links)
- Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis (Q37104907) (← links)